In contrast, low levels of adiponectin are linked with increased prevalence of obesity-associated cardiovascular disorders and detrimental cardiovascular outcomes; therefore, strategies aimed at increasing the adiponectin/leptin ratio have been proposed as a therapeutic approach to cardiovascular dysfunction [16]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.